A project exploring the ‘Study into the Intellectual Property Implications of the Development of Industrial 3D Printing’ was awarded by the European Commission to the Centre for Intellectual Property Policy and Management (CIPPM) in April 2018. The project led by Co-Director of CIPPM, Professor Dinusha Mendis (Principal Investigator), also includes CIPPM members, Dr. Julie Robson… Read more » about Study into the Intellectual Property Implications of the Development of Industrial 3D Printing
Emergent Technologies
CIPPM Secures European Commission Funding for Research into IP and 3D Printing
A project exploring the ‘Study into the Intellectual Property Implications of the Development of Industrial 3D Printing’ was awarded by the European Commission to the Centre for Intellectual Property Policy and Management (CIPPM) in April 2018. The project led by Co-Director of CIPPM, Professor Dinusha Mendis (Principal Investigator), also includes CIPPM members, Dr. Julie Robson… Read more » about CIPPM Secures European Commission Funding for Research into IP and 3D Printing
The effects of ‘Brexit’ on UK IP
Back in 2016 CIPPM hosted a symposium on the effects of the withdrawal from the European Union on UK intellectual property law. Now that we have reached the turning point of the UK/EU negotiations not much clarity as yet been made on the future of IP in the UK – for instance on the fate… Read more » about The effects of ‘Brexit’ on UK IP
IP and Human Genetic Databases
Human genetic databases are large collections of biological samples and personal details of individuals, which can be used for many purposes of medical research. Participants in these projects have expectations of collective benefits resulting from the use of the samples they donate and the information they provide access to. However, the current legal regime does not… Read more » about IP and Human Genetic Databases
Patenting bioprinting technologies
“Three dimensional (3D) bioprinting is the utilization of 3D printing and 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics” (Wikipedia). Bioprinting raises complex ethical and legal issues, at the intersection of law and technology. Dr Marc Mimler‘s newly published book-chapter ‘Patenting Bioprinting-Technologies in the US and Europe: The… Read more » about Patenting bioprinting technologies